Recombinant Human WISP-1/CCN4 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 1627-WS
Key Product Details
Product Specifications
Source
Thr23-Asn367, with a 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is <6.00 µg/mL.
Reviewed Applications
Read 1 review rated 5 using 1627-WS in the following applications:
Formulation, Preparation and Storage
1627-WS
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 250 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: WISP-1/CCN4
Human WISP-1 (Wnt-induced secreted protein-1; also CNN4) is a 40 kDa, secreted, heparin-binding glycoprotein that is a member of the CCN (or CTGF/Cyr61/Nov) cysteine-rich protein family (1-5). It is synthesized as a 367 aa precursor that contains a series of structural homology modules. Following a 22 amino acid (aa) signal sequence, there is a 68 aa IGFBP-like domain (aa 53-120), a 57 aa von Willebrand factor type C (VWC) module (aa 126-182), a 40 aa TSP type I domain (aa 220-259) and a 75 aa, C-terminal cysteine knot motif (aa 273-347). The VWC module is associated with protein-protein interaction, the TSP domain binds sulfated glycoconjugates, and the cysteine knot mediates dimerization and receptor binding (4). It is likely that WISP-1 normally circulates as an 80 kDa homodimer (2). At least five alternative splice forms are known for WISP-1. One is 30 kDa in size, 258 aa in length, and shows a substitution of a His for aa 95-182. This removes the VWC domain (2, 6). A second isoform is 155 aa in length and shows a frameshift at Arg 117 with a unique 38 aa C-terminal extension. A third is 195 aa in length and shows a 31 aa substitution for the first 203 aa of the full length precursor (6). This retains the VWC and cysteine knot domains. A fourth shows a 43 aa substitution for aa 117-367 for a total length of 163 aa. This effectively removes everything but the IGFBP-like domain (7). The last splice form contains a deletion of aa 25-269 for a total length of 122 aa. Thus, only the signal sequence and cysteine knot motifs are retained (8). This leaves only the IGFBP-like domain (9). Full-length mature human WISP-1 is 85% aa identical to both mouse and rat WISP-1. WISP-1 is expressed by osteoblasts and may contribute to fracture healing by promoting bone cell formation (10, 11).
References
- Pennica, D. et al. (1998) Proc. Natl. Acad. Sci. USA 95:14717.
- Tanada, S. et al. (2001) Oncogene 20:5525.
- Brigstock, D.R. et al. (2003) J. Clin. Pathol. Mol. Pathol. 56:127.
- Desnoyers, L. (2004) Curr. Pharm. Des. 10:3913.
- Brigstock, D.R. (2003) J. Endocrinol. 178:169.
- Li, Z. (2005) GenBank Accession # AAP43925.
- Li, Z. (2005) GenBank Accession # AAP43926.
- Li, Z. (2005) GenBank Accession # AAP43924.
- Cervello, M. et al. (2004) Ann. N.Y. Acad. Sci. 1028:432.
- French, D.M. et al. (2004), Am. J. Pathol. 165:855.
- Parisi, M.S. et al. (2006) Bone 38:671.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional WISP-1/CCN4 Products
Product Documents for Recombinant Human WISP-1/CCN4 Protein, CF
Product Specific Notices for Recombinant Human WISP-1/CCN4 Protein, CF
For research use only